Microbial protein display technologies have enabled directed molecular evolution of binding and stability properties in numerous protein systems. In particular, dramatic improvements to antibody binding affinity and kinetics have been accomplished using these tools in recent years. Examples of successful application of display technologies to other immunological proteins have been limited to date. Herein, we describe the expression of human class II major histocompatibility complex allele (MHCII) HLA-DR4 on the surface of Saccharomyces cerevisiae as a noncovalently associated heterodimer. The yeast-displayed MHCII is fully native as assessed by binding of conformationally specific monoclonal antibodies; failure of antibodies specific for empty HLA-DR4 to bind yeast-displayed protein indicates antigenic peptide is bound. This report represents the first example of a noncovalent protein dimer displayed on yeast and of successful display of wildtype MHCII. Results further point to the potential for using yeast surface display for engineering and analyzing the antigen binding properties of MHCII. 
INTRODUCTION
Class II MHC are membrane proteins expressed primarily on the surface of professional antigen presenting cells (APC; e.g., macrophages, dendritic cells, and B cells) and consist of two noncovalently associated chains, α and β (Stern and Wiley 1994) . Each of these chains contains two domains. The peptide antigen binding site is formed from the α1 and β1 domains, while the Ig-like α2 and β2 domains likely aid folding and association in the endoplasmic reticulum.
CD4+ αβ T lymphocytes respond to antigen peptides only when bound to MHCII presented on the surface of APC.
MHCII bound to defined antigenic peptides have been produced using a polypeptide linker attaching the peptide to the β chain N-terminus (Kozono et al. 1994) . Tetramerization of these molecules by site-specific biotinylation (Cull and Schatz 2000) and avidin binding has enabled dramatic progress in the study of T cell-mediated immune phenomena (Altman et al. 1996 ; Kotzin et al. 2000) . Specifically, tracking of antigen-specific T cells during active immune responses in vivo has been become possible (Reijonen and Kwok 2003; Skinner et al. 2000) , as well as screening of putative peptide antigens against T cells to identify reactive peptides (Novak et al. 2001) . Engineered, MHC-based reagents have also shown promise in inhibition of T cell-mediated autoimmune disease (Huan et al. 2004) . Consequently, methods to engineer molecular properties of these important molecules would be of great value.
The utility of directed evolution and display technologies for protein engineering [reviewed by (Chen and Georgiou 2002; Hoogenboom 2002; Pluckthun et al. 2000) ] has been well established in a number of systems including antibodies, enzymes, protease inhibitors, novel binding domains, cytokines, and mammalian cell surface receptor proteins. However, application of this methodology to T cell receptors (TCR) and major histocompatibility complex proteins (MHC), critical surface proteins involved in T cell mediated immune responses, have been few (Chlewicki et al. 2005; Esteban and Zhao 2004; Holler et al. 2003; Holler et al. 2000; Kieke et al. 1999; Shusta et al. 2000; Weidanz et al. 1998) . Phage display of MHC has proved to be particularly challenging, and only three examples of successful display of class I MHC have been demonstrated to date (Kurokawa et al. 2002; Le Doussal et al. 2000; Vest Hansen et al. 2001 ). The lack of MHC phage display data is unsurprising as these proteins are natively heterodimeric with intrachain disulfide bonds; furthermore, at least some MHC proteins demonstrate poor stability or nonnative conformations in the absence of bound antigen peptide (Arimilli et al. 1999; Germain and Rinker 1993) . These issues complicate heterologous expression in prokaryotic hosts, which is a prerequisite for phage display.
In contrast to phage display, yeast surface display relies upon a eukaryotic host for expression of the gene of interest while maintaining the genotype-phenotype linkage requisite for directed molecular evolution. The method has been validated by successful studies applied to numerous single-chain antibodies (Wittrup 2001) , antibody Fab fragments (Lin et al. 2003; Weaver-Feldhaus et al. 2004) , and a single-chain T cell receptor Kieke et al. 1999; Shusta et al. 2000 ). Yeast's ability to perform many of the post-translational modifications typical of secreted mammalian proteins represents a decided advantage of this technology. Three recent studies have demonstrated the ability of yeast to surface display both class I and class II MHC (Brophy et al. 2003; Esteban and Zhao 2004; Starwalt et al. 2003) . A single-chain derivative of an MHCI was successfully displayed, and putatively functional as judged by direct, antigen-specific T cell activation using yeast as the antigen presenting particle (Brophy et al. 2003) . However, the yeast-displayed MHCI in this study (murine H-2K b ) was also expressed by the T cells assayed, and the experiments performed were unable to rule out peptide transfer and T cell autostimulation as the activation mechanism (Ge et al. 2002) . In an elegant study, Kranz and coworkers isolated thermodynamically stabilized mutants of single-chain murine MHCII I-A g7 via screening of combinatorial libraries and demonstrated the importance of two polymorphic β chain positions in this stabilization (Starwalt et al. 2003) . These yeast-displayed MHCII failed to demonstrate peptide binding or T cell activation. Likewise, directed evolution was recently applied to engineer yeast-displayable mutants of a single-chain derivative of HLA-DR1, although data regarding T cell receptor reactivity was not presented (Esteban and Zhao 2004) .
Most significantly, protein mutations were required to achieve expression of DR1 in this system; thus, structure-function studies using this displayed protein must be approached cautiously as the mutant protein properties may not be representative of wild-type HLA-DR1. 
MATERIALS AND METHODS

Yeast expression vectors
Expression vectors for yeast display of DR4 were based upon previously described plasmid pCT302 (Boder et al. 2000) . 
Expression and purification of soluble HLA-DR4
A baculovirus shuttle vector containing p10 and polyhedrin promoters driving expression of HLA-DR4 β with covalent FLU peptide and HLA-DRα extracellular domains was used to cotransfect Sf9 cells along with BaculoGold baculovirus DNA (Pharmingen) according to the manufacturer's instructions. Viral stocks were isolated after 10 days and amplified once by infection of Sf9 cells and culturing for 7 days. The resulting high titer stocks were used to infect suspension-adapted High Five (Invitrogen) cells at 2 x 10 6 cells/mL. Protein was produced by spinner flask culture for 6 days at 27°C in TMN/FH medium plus 10% Pluronic F-68.
Assembled HLA-DR4-FLU heterodimers were purified from culture supernatants by affinity chromatography. Anti-DRα mAb LB3.1 was produced from hybridoma culture, purified by protein A-Sepharose affinity chromatography (Pharmacia), and coupled to activated CNBrSepharose.
Following affinity chromatography, monomeric DRα chain was removed by size exclusion chromatography (Pharmacia FPLC, Superdex 10/200). Heterodimer identity was confirmed by reducing and non-reducing SDS-PAGE electrophoresis and Coomassie staining.
DR4-FLU protein was concentrated to ~4 mg/mL and enzymatically biotinylated as described (Crawford et al. 1998) . Free biotin was removed by FPLC, and biotin incorporation was confirmed by avidin-agarose depletion and quantitative ELISA using anti-DR4β mAb L227 and biotinylated anti-DRα mAb LB3.1.
Immunofluorescent staining and flow cytometry
3 mL of SD-CAA (Boder et al. 2000) were inoculated with a single yeast colony and grown overnight at 30° to an OD 600 of 2.0 -5.0. 3 x 10 7 cells were collected, switched to 3 mL SG-CAA (galactose replaces glucose) + 10% glycerol, grown 24 hrs at 30°C, then stored at 4°C.
1.6 x 10 7 cells were collected, spun, resuspended in 1 mL PBSB (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 1% (w/v) BSA, pH 7.4), spun again, resuspended in 0.4 mL PBSB, and incubated at 80°C for 1 hr. A control group was kept at 4°C. After the 80°C incubation, both sets of cells were washed twice with 1 mL PBSB and resuspended in 0.8 mL PBSB. 100 µL aliquots of these suspensions (~ 2 
T cell activation assays
75IP fibroblasts transfected with HLA-DR4 (Boen et al. 2000) were cultured in D-MEM (LTI) + 10% FCS. FLU-specific and HLA-DR4-restricted T cell hybridoma HA1.7 (Lamb et al. 1982) were cultured in complete tumor media (CTM) (Kappler et al. 1981) . To test for T cell activation, stimulating particles (10 5 for fibroblasts, or 2 x 10 5 -1 x 10 6 for yeast or antigencoated beads) were added to a 96-well plate to a final volume of 250 µL. 75IP-DR4-FLU positive controls elicited >1200 U/mL IL-2 in all experiments. In some experiments, yeast were lethally UV irradiated prior to the assay using a Stratalinker UV crosslinking apparatus (Stratagene) at ~1 J/cm 2 for 3 mins. This prevented overgrowth of the culture during the overnight stimulation assay. Following incubation for 24 hrs at 37°C in 5% CO 2 , medium supernatants were isolated and IL-2 levels were assayed by the HT-2 bioassay (Kappler et al. 1981) . Wells containing live HT-2 cells were identified by light microscopy following overnight incubation in serially diluted activation supernatants.
RESULTS
Yeast expression of HLA-DR4flu
Yeast display of proteins has been commonly accomplished by recombinant expression of the protein of interest fused to the Aga2p subunit of a-agglutinin, a cell wall protein involved in cell-cell adhesion during mating (Shen et al. 2001) . Two constructs were developed to test surface expression of human MHCII HLA-DR4 in yeast (Figure 1 ). Both constructs attached the Aga2p fusion partner to a covalent peptide-MHCII β chain construct via an intervening (Gly 4 -Ser) 3 linker sequence. The influenza hemagglutinin 307 -319 peptide (FLU) was attached to DR4β through a previously described flexible linker segment (Kozono et al. 1994 ). One fusion (construct A) incorporated Aga2p at the N-terminus of the FLU-DR4β protein, a format similar to that used in prior yeast display studies (Boder and Wittrup 2000) . N-terminal extensions appended to covalently associated peptides have been previously shown to affect the conformation of MHCII (Rotzschke et al. 1999 ); thus, a second construct with the Aga2p fusion partner linked to the C-terminus of FLU-DR4β was designed. In both cases, the DRα chain was expressed as a soluble protein from a separate cassette making use of the bidirectional GAL1-10 promoter, as shown in Figure 1 . Heterodimeric protein expression on the yeast surface was assessed by immunofluorescent staining. As shown in Figures 2 and 3(B) , mAb specific for both the α (L243 and LB3.1) and β (L227) chains of DR4 recognize the yeast-displayed protein.
Furthermore, binding of both L243 and LB3.1 is sensitive to native conformation and heterodimeric assembly of HLA-DR molecules (Horejsi et al. 1986 ). These data therefore indicate that yeast-displayed HLA-DR4 is assembled as a native heterodimer. Yeast expressing construct A exhibit little reactivity with L227 and substantially lower reactivity with L243 and LB3.1 in comparison to construct B; thus, linkage of the Aga2p fusion partner at the C-terminus of MHCII β appears to be necessary for efficient expression in this context.
Peptide loading status of yeast-displayed HLA-DR4
To confirm that peptides were indeed loaded in the antigen-binding groove of yeast Figure 1) . In this study, we have tested the ability of yeast to display an additional human MHCII, HLA-DR4, and we have assessed two fusion protein formats in which the Aga2p anchoring partner is linked to the N-and C-terminus of the DR4β chain, respectively (Figure 1 ).
The C-terminal Aga2p fusion (construct B) more closely mimics the anchoring mechanism of MHCII expressed on APC via transmembrane domains at the C-terminus of both the α and β chains. The data indicate that HLA-DR4 expresses well with a C-terminal Aga2p (construct B)
but with an N-terminal Aga2p expresses at levels sufficiently low to preclude detection of DR4β by immunofluorescent staining (Figures 2 and 3A,B) . These data are consistent with previous reports on yeast display of other MHCII (Starwalt et al. 2003; Esteban and Zhao 2004) but further indicate that successful display of wild-type MHCII on yeast is possible using the appropriate fusion protein system (construct B in Figure 1 ).
Staining with conformationally sensitive antibodies enables probing of DR4 conformational state and peptide loading (Figure 3) . Our results indicate that yeast-displayed DR4 is native; furthermore, mAb L243 reportedly fails to react with isolated DRα chain (Horejsi et al. 1986 ), presumably because the MHCII α chain fails to fold natively in the absence of the β chain. Heat denaturation of the yeast quantitatively abrogates L243 binding, as expected for a noncovalently associated heterodimer. Thus, this work represents the first demonstration that yeast surface display is not limited to simple single-chain protein display or disulfide-bonded Fab display, but can also be used to successfully display complex noncovalent multimers.
Monoclonal antibodies directed against a β chain epitope that is masked in native, peptide-loaded DR4 fail to react with DR4-displaying yeast, but demonstrate significant binding following heat denaturation, as shown in Figure 3C . These results strongly suggest that the yeast-displayed DR4 is functional in terms of peptide binding activity.
We were unable to demonstrate T cell receptor binding activity of our yeast-displayed protein; however, yeast coated with functional DR4 produced in insect cells likewise failed to demonstrate activity. Fluorescent tetramers of chimeric human/mouse HA1.7 TCR also failed to stain DR4-displaying yeast, but these reagents also failed to stain 75IP-DR4-FLU fibroblasts (which activate HA1.7 T cells) and thus this result is inconclusive (data not shown). BIAcore analysis of monomeric HA1.7 TCR binding to baculovirus-produced DR4-FLU suggests the affinity is low (> 50 µM; E.T. Boder, P.C. Marrack, J.W. Kappler, unpublished observations) and thus insufficient for TCR tetramer binding, which occurs in the absence of avidity-enhancing CD4 binding.
Interestingly, 2.8 µm streptavidin-coated magnetic beads incubated with bvDR4 also failed to stimulate detectable IL-2 production from HA1.7 T cells (data not shown). Previous experiments have indicated that CD8+ cytotoxic T lymphocyte (CTL) activation by pMHCI adsorbed to latex microspheres requires "cell sized" particles ~5 µm diameter (Mescher 1992) .
Beads 1 -2 µm in diameter yielded no CTL activity, while 5 µm beads stimulated a weak response. Valitutti and colleagues also showed a similar effect in a CD8 T cell system (Zaru et al. 2002) . pMHC-coated polystyrene beads weakly stimulated antigen-specific T cells, but coimmobilization of anti-CD2 mAb potentiated T cell activation. Particles presenting a T cell contact surface with a small radius of curvature seem to yield nonproductive interaction despite the presence of cognate pMHC-TCR interaction.
Taken together with our data, these results suggest that geometry of the antigenpresenting particle may be important for both CD8 and CD4 T cell stimulation, at least by artificial antigen-presenting particles lacking co-stimulatory interactions. It is noteworthy that the antigen-presenting particles in the current study (yeast) and those discussed above (synthetic beads) present spatially restricted ligands incapable of two-dimensional diffusion on the surface of the particle; thus, supramolecular activation cluster (Monks et al. 1998) or immunological synapse (Bromley et al. 2001) formation is not possible in these systems regardless of the presence of costimulatory ligands. Although these spatial patterns have been suggested as important to both thymic selection and peripheral T cell activation in vivo (Jacobelli et al. 2004; Lee et al. 2003a; Lee et al. 2002; Minter and Osborne 2003) , synapse formation is clearly not required for T cell stimulation in all cases. Nonetheless, it would be interesting to investigate the effects of antigen presenting particle size on T cell stimulation in a system allowing ligand diffusion on the presenting particle, such as a lipid vesicle. This information might further corroborate physical models of the T cell-APC interaction in which T cell membrane bending modulus and thermal fluctuations play a critical role in spatial pattern formation, with apparent effects on signaling and activation (Lee et al. 2003b; Lee et al. 2002) .
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